Lub siab -kev ruaj khov Lactobacillus rhamnosus CCFM0528 yog qhov kev xaiv zoo tshaj plaws rau kev saib xyuas lub plab txhua hnub thiab kev txhawb nqa metabolic vim tias nws muaj peev xwm ua rau lub plab hnyuv muaj zog los pab kho. Rov qab los ntawm lub teb chaws invention patent, nws pab txhawb lub plab noj qab haus huv thiab pab tswj cov suab thaj thiab lipid metabolism. Raws li kev ua haujlwm siab heev thiab bioavailable ua haujlwm, nws yog tsim los kom ruaj khov thiab ua haujlwm zoo nyob rau hauv txoj hnyuv ib puag ncig, muab kev txhawb nqa rau cov tib neeg uas muaj lub siab rhiab heev thiab kev tswj hwm cov kev xav tau ntawm metabolic.
Qhov kev sib xyaw ua ke ntawm "bidirectional modulation" thiab "high stability" stems los ntawm nws lub peev xwm colonization muaj peev xwm ua lub hauv paus ntawm kev tshawb fawb ntau - lim formulations. Rau cov tib neeg uas muaj cov kab mob digestive rhiab heev uas muaj kev sib hloov cem quav thiab raws plab, CCFM0528 pab txhawb lub plab microbiome thiab txhawb kev noj qab haus huv. Tsis tas li ntawd, nws cov hmoov hmoov zoo heev pab tswj kev ua kom muaj zog ua ntej mus txog cov hnyuv, ua rau nws yog qhov kev xaiv zoo tshaj plaws rau kev tu plab txhua hnub los txhawb kev zom zaub mov.
Tsis tas li ntawd, CCFM0528 qhia txog kev tshawb fawb txog kev tshawb fawb muaj zog thiab patented technologies hauv kev txhawb nqa metabolic. Cov kev tshawb fawb tshawb fawb qhia tau hais tias kev tswj hwm qhov ncauj ntawm cov kab mob no pab txhawb cov piam thaj hauv cov ntsiab lus ntawm kev noj zaub mov muaj roj siab - thiab pab hloov qhov tso tawm ntawm cov cytokines ntsig txog. Tsis tas li ntawd, raws li nws qhov tshwj xeeb -glucosidase inhibitory kev ua haujlwm, CCFM0528 qhia tau tias muaj peev xwm hauv kev cuam tshuam metabolic. Kev koom ua ke hauv paus kev saib xyuas lub plab nrog kev txhawb nqa metabolic, nws sawv tawm hauv kev txhim kho cov khoom noj khoom haus thiab cov khoom noj rau cov hom phiaj kho mob tshwj xeeb (FSMP), muab cov tswv lag luam nrog cov kev daws teeb meem sib tw.